DK1169029T3 - Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser - Google Patents

Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser

Info

Publication number: DK1169029T3
Authority: DK; Denmark
Prior art keywords: sibutramine; derivative; treatment; sleep disorders; snoring
Prior art date: 1999-03-19

Application number

DK00918094T

Other languages

English (en)

Inventor

Carl M Mendel

Timothy B Seaton

Steve P Weinstein

Sharon Crawford Cheetham

David John Heal

Anton Safer

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-19

Filing date

2000-03-17

Publication date

2005-08-29

2000-03-17 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2005-08-29 Application granted granted Critical

2005-08-29 Publication of DK1169029T3 publication Critical patent/DK1169029T3/da

Links

UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 title 1
229960004425 sibutramine Drugs 0.000 title 1
208000019116 sleep disease Diseases 0.000 title 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
206010041235 Snoring Diseases 0.000 abstract 1
UWAOJIWUVCMBAZ-UHFFFAOYSA-N [1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-dimethylazanium;chloride Chemical compound Cl.C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UWAOJIWUVCMBAZ-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
150000004682 monohydrates Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
201000002859 sleep apnea Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Fluid-Pressure Circuits (AREA)
Harvester Elements (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DK00918094T 1999-03-19 2000-03-17 Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser DK1169029T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12518599P	1999-03-19	1999-03-19
PCT/US2000/007177 WO2000056314A1 (en)	1999-03-19	2000-03-17	Method of treating sleep apnoea

Publications (1)

Publication Number	Publication Date
DK1169029T3 true DK1169029T3 (da)	2005-08-29

Family

ID=22418567

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00918094T DK1169029T3 (da)	1999-03-19	2000-03-17	Anvendelse af sibutramin eller et derivat deraf til behandling af sövnforstyrrelser

Country Status (26)

Country	Link
US (1)	US6365631B1 (da)
EP (1)	EP1169029B1 (da)
JP (1)	JP2003521469A (da)
KR (1)	KR100682291B1 (da)
CN (1)	CN1161114C (da)
AT (1)	ATE294573T1 (da)
AU (1)	AU773489B2 (da)
BG (1)	BG106001A (da)
BR (1)	BR0009080A (da)
CA (1)	CA2367022A1 (da)
CZ (1)	CZ298293B6 (da)
DE (1)	DE60019914T2 (da)
DK (1)	DK1169029T3 (da)
ES (1)	ES2244420T3 (da)
HK (1)	HK1044462B (da)
HU (1)	HUP0200501A3 (da)
IL (2)	IL145244A (da)
MX (1)	MXPA01009464A (da)
NO (1)	NO20014475L (da)
NZ (1)	NZ514014A (da)
PL (1)	PL359467A1 (da)
PT (1)	PT1169029E (da)
SI (1)	SI1169029T1 (da)
SK (1)	SK285308B6 (da)
WO (1)	WO2000056314A1 (da)
ZA (1)	ZA200107678B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6476078B2 (en)	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en)	1998-08-24	2005-12-13	Sepracor Inc.	Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en)	1999-08-11	2002-06-04	Sepracor Inc.	Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en)	2001-04-13	2002-10-24	Sepracor Inc.	Methods of preparing didesmethylsibutramine and other sibutramine derivatives
MXPA05003355A (es) *	2002-10-05	2005-10-18	Hanmi Pharm Ind Co Ltd	Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino.
US20050131074A1 (en) *	2003-08-04	2005-06-16	Beckman Kristen M.	Methods for treating metabolic syndrome
US20050228052A1 (en) *	2004-01-29	2005-10-13	Barberich Timothy J	Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
ATE454140T1 (de) *	2004-02-18	2010-01-15	Sepracor Inc	Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
KR100627687B1 (ko) *	2005-04-20	2006-09-25	주식회사 씨티씨바이오	시부트라민 유리염기 함유 조성물 및 이의 제조방법
BRPI0716002A2 (pt) *	2006-11-22	2013-07-30	Sk Chemicals Co Ltd	complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8531071D0 (en)	1985-12-17	1986-01-29	Boots Co Plc	Therapeutic compound
IE61928B1 (en) *	1988-11-29	1994-11-30	Boots Co Plc	Treatment of obesity
US5356934A (en) *	1990-03-29	1994-10-18	Eli Lilly And Company	Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en)	1994-02-03	1995-10-17	Boots Pharmaceuticals, Inc.	Medical treatment

2000
- 2000-03-17 HU HU0200501A patent/HUP0200501A3/hu unknown
- 2000-03-17 AT AT00918094T patent/ATE294573T1/de not_active IP Right Cessation
- 2000-03-17 MX MXPA01009464A patent/MXPA01009464A/es active IP Right Grant
- 2000-03-17 CN CNB008075328A patent/CN1161114C/zh not_active Expired - Fee Related
- 2000-03-17 PL PL00359467A patent/PL359467A1/xx unknown
- 2000-03-17 BR BR0009080-8A patent/BR0009080A/pt not_active IP Right Cessation
- 2000-03-17 EP EP00918094A patent/EP1169029B1/en not_active Expired - Lifetime
- 2000-03-17 SK SK1338-2001A patent/SK285308B6/sk unknown
- 2000-03-17 AU AU38968/00A patent/AU773489B2/en not_active Ceased
- 2000-03-17 CZ CZ20013280A patent/CZ298293B6/cs not_active IP Right Cessation
- 2000-03-17 IL IL145244A patent/IL145244A/en active IP Right Grant
- 2000-03-17 US US09/527,814 patent/US6365631B1/en not_active Expired - Fee Related
- 2000-03-17 ES ES00918094T patent/ES2244420T3/es not_active Expired - Lifetime
- 2000-03-17 DE DE60019914T patent/DE60019914T2/de not_active Expired - Fee Related
- 2000-03-17 HK HK02104531.6A patent/HK1044462B/en not_active IP Right Cessation
- 2000-03-17 WO PCT/US2000/007177 patent/WO2000056314A1/en not_active Ceased
- 2000-03-17 DK DK00918094T patent/DK1169029T3/da active
- 2000-03-17 CA CA002367022A patent/CA2367022A1/en not_active Abandoned
- 2000-03-17 SI SI200030672T patent/SI1169029T1/sl unknown
- 2000-03-17 PT PT00918094T patent/PT1169029E/pt unknown
- 2000-03-17 NZ NZ514014A patent/NZ514014A/xx unknown
- 2000-03-17 JP JP2000606219A patent/JP2003521469A/ja not_active Withdrawn
- 2000-03-17 KR KR1020017011955A patent/KR100682291B1/ko not_active Expired - Fee Related
2001
- 2001-09-14 NO NO20014475A patent/NO20014475L/no not_active Application Discontinuation
- 2001-09-18 ZA ZA200107678A patent/ZA200107678B/en unknown
- 2001-10-10 BG BG106001A patent/BG106001A/xx unknown
2006
- 2006-08-22 IL IL177626A patent/IL177626A0/en unknown

Also Published As

Publication number	Publication date
EP1169029A4 (en)	2004-01-21
PL359467A1 (en)	2004-08-23
US6365631B1 (en)	2002-04-02
IL177626A0 (en)	2006-12-31
SK13382001A3 (sk)	2002-04-04
ES2244420T3 (es)	2005-12-16
PT1169029E (pt)	2005-08-31
NZ514014A (en)	2004-02-27
JP2003521469A (ja)	2003-07-15
DE60019914D1 (de)	2005-06-09
DE60019914T2 (de)	2006-05-04
HK1044462B (en)	2006-03-03
CN1356897A (zh)	2002-07-03
KR100682291B1 (ko)	2007-02-15
HK1044462A1 (en)	2002-10-25
HUP0200501A2 (en)	2002-08-28
WO2000056314A1 (en)	2000-09-28
CN1161114C (zh)	2004-08-11
NO20014475L (no)	2001-11-14
MXPA01009464A (es)	2004-03-19
ATE294573T1 (de)	2005-05-15
KR20010113847A (ko)	2001-12-28
NO20014475D0 (no)	2001-09-14
SI1169029T1 (sl)	2005-12-31
CZ20013280A3 (cs)	2002-07-17
EP1169029B1 (en)	2005-05-04
HUP0200501A3 (en)	2004-03-29
ZA200107678B (en)	2003-06-18
BR0009080A (pt)	2002-02-13
SK285308B6 (sk)	2006-10-05
AU773489B2 (en)	2004-05-27
BG106001A (en)	2002-06-28
AU3896800A (en)	2000-10-09
CZ298293B6 (cs)	2007-08-15
IL145244A0 (en)	2002-06-30
EP1169029A1 (en)	2002-01-09
IL145244A (en)	2006-12-10
CA2367022A1 (en)	2000-09-28

Publication	Publication Date	Title
DE60039508D1 (de)	2008-08-28	Methoden zur behandlung der essstörungen
NO20021328L (no)	2002-05-21	Pyrazolopyrimidier som terapeutiske midler
PT1007023E (pt)	2003-08-29	Derivados de 1-¬1-(4-clorofenil)ciclobutil\|-3-metil-butil amina para reducao dos niveis de acido urico em seres humanos
DE60019914D1 (de)	2005-06-09	Verwendung von Sibutramin oder dessem Derivat zur Behandlung von Schlafstörungen
WO2000056315A8 (en)	2001-06-21	Treatment of pain
MXPA01009461A (es)	2004-03-19	Tratamiento de osteoartritis.
HK1045254A1 (zh)	2002-11-22	降低血小板黏性的处理方法
BG106000A (en)	2002-06-28	Treatment of hiatial hernia
WO2004026930A3 (en)	2004-09-23	The method for reducing inflammation using sti-571 or its salt
MXPA01009462A (es)	2004-03-19	Tratamiento de calculos biliares.
MXPA01009465A (es)	2004-03-19	Perdida de peso despues del embarazo.
NO20053612L (no)	2005-09-23	1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet